Infographic_fon-2021-1006.pdf (2.18 MB)
Infographic – Summary of the CaboPoint study
figure
posted on 2021-12-20, 14:30 authored by Laurence Albiges, Manuela Schmidinger, Naila Taguieva-Pioger, David Perol, Viktor Grünwald, Eric GuemasCaboPoint: a Phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinoma